RecruitingNot ApplicableNCT07046546

Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules

Thyroid ARtery Goitre Embolization Trial: A Service Introduction and Safety Assessment


Sponsor

Royal Berkshire NHS Foundation Trust

Enrollment

10 participants

Start Date

Sep 29, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Large non-cancerous thyroid nodules (lumps in the thyroid gland) can cause pressure or discomfort in the neck or cosmetic issues. The standard treatment options include radiofrequency ablation, radioactive iodine, and surgery. Not all patients are suitable however for these treatments, some lumps are too large, or the patients are not fit enough for surgery. Thyroid artery embolization (TAE) is a new minimally invasive technique (smaller incisions / cuts and shorter recovery time) performed under light sedation. It is used by other European Thyroid Centres, but it hasn't been used in the UK. Embolization means arteries supplying the thyroid gland are blocked by injecting small occlusive particles, like very fine grains of sand that can get stuck in small spaces, preventing blood from passing through. Blocking the thyroid arteries causes the gland to shrink. This provides symptom relief or controls an overactive gland. We aim to undertake a TAE pilot study to explore the safety of TAE in a UK patient population. We are planning to recruit 10 eligible patients. We will also collect additional data (for example on pain, effectiveness, cost and health related quality of life) to inform a future larger trial comparing TAE to other treatment options.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is testing thyroid artery embolization (TAE) — a minimally invasive procedure where a radiologist blocks the blood supply to a large thyroid nodule to shrink it — as an alternative to surgery or radioiodine for people with bothersome or large benign thyroid lumps. **You may be eligible if...** - You are over 18 with a large or symptomatic benign thyroid nodule or goiter - Your nodule has been confirmed benign by ultrasound and needle biopsy - Your nodule is causing symptoms (difficulty swallowing, pressure, visible neck lump) or cosmetic concerns - You have discussed all treatment options with your specialist and prefer this approach - You can lie flat on a procedure table for at least 2 hours **You may NOT be eligible if...** - Your nodule shows suspicious features for cancer - You have malignant or indeterminate biopsy results - You have enlarged or suspicious lymph nodes in your neck - You are unable to tolerate the procedure - You are allergic to the contrast dye used Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREThyroid artery embolization

A minimally invasive procedure where one or more thyroid arteries are occluded to shrink the thyroid gland or thyroid nodules


Locations(1)

Royal Berkshire Hospital

Reading, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07046546


Related Trials